Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-31 @ 5:54 PM
Study NCT ID:
NCT01955434
Status:
COMPLETED
Last Update Posted:
2019-09-10
First Post:
2013-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
None
Primary Completion Date:
2016-06-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-27
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-27
First Submit QC Date:
None
Study First Post Date:
2013-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-16
Results First Submit QC Date:
None
Results First Post Date:
2018-02-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-29
Last Update Post Date:
2019-09-10
Last Update Post Date Type:
ACTUAL